The proportion of patients with HLA-A*03 or HLA-A*11 alleles was found to be lower in lymphoproliferative disorders cases than in CHC (19.6% versus 32.8%, p < 0.01). This evidence concerns the gene HLA-A and cryohydrocytosis.